Chad Spooner - 11 Mar 2026 Form 4 Insider Report for MiniMed Group, Inc. (MMED)

Reporting relationship: EVP, Chief Financial Officer
Issuer ticker: MMED
Reported as of: 11 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Mar 2026, 19:24:30 UTC
Prior SEC filing: 11 Mar 2026
Next SEC filing: 06 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Bryan F. Kelly, attorney-in-fact

Key filing fact

Chad Spooner filed Form 4 for MiniMed Group, Inc. (MMED) on 13 Mar 2026.

Key facts

This page summarizes Chad Spooner's Form 4 filing for MiniMed Group, Inc. (MMED).
3 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Mar 2026, 19:24.

Change

Previous filing in this sequence was filed on 11 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002111465 Primary reporting owner

Spooner Chad

Relationship: EVP, Chief Financial Officer
Address: C/O 18000 DEVONSHIRE STREET, NORTHRIDGE
Signature: /s/ Bryan F. Kelly, attorney-in-fact
Signature date: 13 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMED transaction

Common Stock

Award

Transaction value
Shares: +70,896
Change %
Price
Shares after: 70,896
Date: 11 Mar 2026
Ownership: Direct
Footnotes: F1, F2, F3, F4

MMED transaction

Common Stock

Award

Transaction value
Shares: +127,609
Change %
Price
Shares after: 127,609
Date: 11 Mar 2026
Ownership: Direct
Footnotes: F1, F2, F4, F5

MMED transaction

Common Stock

Award

Transaction value
Shares: +70,896
Change %
Price
Shares after: 70,896
Date: 11 Mar 2026
Ownership: Direct
Footnotes: F1, F2, F4, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA").

Footnote F2

Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion").

Footnote F3

Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 28, 2028.

Footnote F4

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

Footnote F5

Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028.

Footnote F6